SU5416 does not attenuate early RV angiogenesis in the murine chronic hypoxia PH model.

scientific article published on 17 June 2019

SU5416 does not attenuate early RV angiogenesis in the murine chronic hypoxia PH model. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1186/S12931-019-1079-X
P932PMC publication ID6580559
P698PubMed publication ID31208454

P50authorTodd M KolbQ89564966
P2093author name stringPaul M Hassoun
Laura Johnston
Mahendra Damarla
Rachel L Damico
Grace L Peloquin
P2860cites workNIH Image to ImageJ: 25 years of image analysisQ23319322
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applicationsQ24561689
Angiopoietin-1 is essential in mouse vasculature during development and in response to injuryQ24629743
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Q25938983
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodQ25938999
Paraffin wax embedded muscle is suitable for the diagnosis of muscular dystrophyQ28367914
Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endotheliumQ28512027
High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesisQ28594191
Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR dataQ33411668
An inside view: VEGF receptor trafficking and signalingQ33682832
VEGFR2 translocates to the nucleus to regulate its own transcriptionQ34043465
The Sugen 5416/hypoxia mouse model of pulmonary hypertension revisited: long-term follow-upQ34782558
Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure.Q35010981
Bovine brain and pituitary fibroblast growth factors: comparison of their abilities to support the proliferation of human and bovine vascular endothelial cellsQ36208553
Right Ventricular Angiogenesis is an Early Adaptive Response to Chronic Hypoxia-Induced Pulmonary HypertensionQ36470065
Phenotypic heterogeneity of the endothelium: II. Representative vascular bedsQ36726076
A critical analysis of current in vitro and in vivo angiogenesis assaysQ37534963
A simple tool for stereological assessment of digital images: the STEPanizerQ39973738
Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxideQ40342883
The multi-targeted kinase inhibitor SU5416 inhibits small cell lung cancer growth and angiogenesis, in part by blocking Kit-mediated VEGF expressionQ40492600
Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesisQ40736486
New models of pulmonary hypertension based on VEGF receptor blockade-induced endothelial cell apoptosisQ41853468
Cardiac glutaminolysis: a maladaptive cancer metabolism pathway in the right ventricle in pulmonary hypertensionQ42145037
Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinasesQ42541293
Pivotal role of cardiomyocyte TGF-β signaling in the murine pathological response to sustained pressure overloadQ42741838
SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor typesQ42820704
The angiogenesis inhibitor SU5416 has long-lasting effects on vascular endothelial growth factor receptor phosphorylation and functionQ42832614
Inhibition of RET tyrosine kinase by SU5416.Q42834571
Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive ratsQ43052157
A novel murine model of severe pulmonary arterial hypertensionQ43409467
A metabolic remodeling in right ventricular hypertrophy is associated with decreased angiogenesis and a transition from a compensated to a decompensated state in pulmonary hypertensionQ46547034
Effect of voluntary exercise on number and volume of cardiomyocytes and their mitochondria in the mouse left ventricleQ48743962
Growth hormone increases the proliferation of existing cardiac myocytes and the total number of cardiac myocytes in the rat heart.Q51743635
Intrinsic tyrosine kinase activity is required for vascular endothelial growth factor receptor 2 ubiquitination, sorting and degradation in endothelial cells.Q52855186
Right Ventricle Vasculature in Human Pulmonary Hypertension Assessed by Stereology.Q52893502
Downregulation of MicroRNA-126 Contributes to the Failing Right Ventricle in Pulmonary Arterial Hypertension.Q54259993
Capillary Degeneration and Right Ventricular Remodeling Due to Hypoxic Stress with Sugen5416.Q55000946
Fischer rats exhibit maladaptive structural and molecular right ventricular remodelling in severe pulmonary hypertension: a genetically prone model for right heart failureQ57790481
Postnatal growth of cardiomyocytes in the left ventricle of the ratQ76382071
Fluid shear stress-induced transcriptional activation of the vascular endothelial growth factor receptor-2 gene requires Sp1-dependent DNA bindingQ78862751
Signal transduction by vascular endothelial growth factor receptorsQ84520249
P433issue1
P921main subjecthypoxiaQ105688
P304page(s)123
P577publication date2019-06-17
P1433published inRespiratory ResearchQ7315904
P1476titleSU5416 does not attenuate early RV angiogenesis in the murine chronic hypoxia PH model
P478volume20

Search more.